Hologen

Hologen is an early-stage biotechnology company focused on leveraging the hologenome—the collective genome of a host and its associated microbiome—to discover and develop novel therapeutics. By analyzing the complex interactions between human cells and microbial communities, the company aims to identify unique biological targets and pathways that are overlooked by traditional genomic approaches. Hologen's platform integrates advanced computational biology with high-throughput screening to accelerate the discovery of small molecules and microbial-based therapies. The company's primary research efforts are directed toward addressing unmet needs in inflammatory diseases, metabolic health, and oncology.